• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻与早期 luminal B 型乳腺癌患者接受乳房切除术的不良结局相关。

Young age is associated with inferior outcomes in early-stage luminal B breast cancer patients who undergo mastectomy.

机构信息

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.

出版信息

Future Oncol. 2023 Mar;19(10):715-726. doi: 10.2217/fon-2023-0083. Epub 2023 May 2.

DOI:10.2217/fon-2023-0083
PMID:37129057
Abstract

This retrospective study aimed to evaluate the effect of age on cancer relapse and survival in breast cancer patients undergoing different treatments. The propensity score method was used to correct for disparities between two groups; 2049 young patients were matched to 4053 older patients. Kaplan-Meier curves and Cox proportional hazards models were used to assess disease-free survival. In the original cohort, young patients showed higher lymph node metastasis, hormone-receptor positivity and high Ki-67 levels. After propensity score matching, the disease-free survival of young patients with the luminal B-like subtype who received mastectomy with early stage disease exhibited inferior survival. Decisions about biology-driven systemic treatment strategies for young patients are worthy of discussion with a multidisciplinary tumor board.

摘要

本回顾性研究旨在评估年龄对接受不同治疗的乳腺癌患者癌症复发和生存的影响。采用倾向评分法校正两组间的差异;将 2049 例年轻患者与 4053 例老年患者进行匹配。采用 Kaplan-Meier 曲线和 Cox 比例风险模型评估无病生存。在原始队列中,年轻患者表现出更高的淋巴结转移、激素受体阳性和高 Ki-67 水平。在倾向评分匹配后,早期疾病接受乳房切除术的 luminal B 样亚型的年轻患者的无病生存显示出较差的生存。年轻患者的生物学驱动的系统治疗策略决策值得与多学科肿瘤委员会讨论。

相似文献

1
Young age is associated with inferior outcomes in early-stage luminal B breast cancer patients who undergo mastectomy.年轻与早期 luminal B 型乳腺癌患者接受乳房切除术的不良结局相关。
Future Oncol. 2023 Mar;19(10):715-726. doi: 10.2217/fon-2023-0083. Epub 2023 May 2.
2
Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.保乳手术联合放疗与乳房切除术治疗Ⅰ期乳腺癌患者的疗效比较:倾向评分匹配分析。
Clin Breast Cancer. 2018 Oct;18(5):e975-e984. doi: 10.1016/j.clbc.2018.06.002. Epub 2018 Jun 27.
3
Evaluation of Local Oncologic Safety in Nipple-Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched Study.原发性化疗后保留乳头乳晕复合体的乳房切除术中局部肿瘤学安全性的评估:一项倾向评分匹配研究
Clin Breast Cancer. 2017 Jun;17(3):219-231. doi: 10.1016/j.clbc.2016.12.003. Epub 2016 Dec 24.
4
Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.在现代治疗时代,乳房切除术后放疗对1至3个阳性淋巴结的乳腺癌患者局部区域复发的影响极小。
Surg Oncol. 2017 Jun;26(2):163-170. doi: 10.1016/j.suronc.2017.03.003. Epub 2017 Mar 16.
5
Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.保乳治疗与乳房切除术在年轻乳腺癌患者中与分子亚型的比较:一项 SEER 基于人群的研究。
Cancer Control. 2020 Jan-Dec;27(1):1073274820976667. doi: 10.1177/1073274820976667.
6
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.基于真性复发和新发原发性肿瘤分类的保乳治疗后同侧乳腺肿瘤复发分析
Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104.
7
Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.分子亚型对T1-T2期乳腺癌且腋窝淋巴结1-3枚阳性的乳房切除患者局部区域复发的影响。
Ann Surg Oncol. 2014 May;21(5):1569-74. doi: 10.1245/s10434-014-3488-x. Epub 2014 Feb 1.
8
Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.保乳手术后最大直径小于或等于 2cm 的乳腺癌免疫组化定义亚型的长期预后
J Surg Res. 2019 Apr;236:288-299. doi: 10.1016/j.jss.2018.11.028. Epub 2018 Dec 27.
9
Long-term survival outcomes of repeat lumpectomy for ipsilateral breast tumor recurrence: a propensity score-matched analysis.重复保乳术治疗同侧乳房肿瘤复发的长期生存结果:倾向评分匹配分析。
Breast Cancer Res Treat. 2021 Jan;185(1):155-164. doi: 10.1007/s10549-020-05932-8. Epub 2020 Sep 15.
10
Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.早期乳腺癌中青年女性保乳治疗与乳房切除术的比较:采用倾向评分调整方法的长期结果。
Breast Cancer Res Treat. 2020 Oct;183(3):717-728. doi: 10.1007/s10549-020-05821-0. Epub 2020 Jul 26.

引用本文的文献

1
Neoadjuvant response stratification based on complete, partial, and no response in HR-positive/HER2-positive breast cancer.基于HR阳性/HER2阳性乳腺癌的完全缓解、部分缓解和无缓解情况进行新辅助治疗反应分层。
Breast Cancer Res Treat. 2025 Aug 28. doi: 10.1007/s10549-025-07812-5.
2
Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer.儿童癌症女性幸存者后续患乳腺癌后的治疗、毒性和死亡率。
Nat Commun. 2025 Mar 31;16(1):3088. doi: 10.1038/s41467-025-58434-w.